American International Group, Inc. Esperion Therapeutics, Inc. Transaction History

American International Group, Inc.

$8.5 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$1.46 - $7.3 $1,032 - $5,161	707 Added 2.03%	35,594 $56,000
Q4 2022 Feb 10, 2023	BUY	$5.09 - $8.5 $16,608 - $27,735	3,263 Added 10.32%	34,887 $217,000
Q3 2022 Nov 14, 2022	BUY	$5.45 - $8.13 $11,483 - $17,129	2,107 Added 7.14%	31,624 $212,000
Q2 2022 Aug 12, 2022	BUY	$4.77 - $6.67 $4,002 - $5,596	839 Added 2.93%	29,517 $188,000
Q1 2022 May 13, 2022	BUY	$3.34 - $5.56 $47,728 - $79,452	14,290 Added 99.32%	28,678 $133,000
Q4 2021 Feb 11, 2022	BUY	$4.81 - $11.92 $96 - $238	20 Added 0.14%	14,388 $72,000
Q3 2021 Nov 12, 2021	SELL	$11.34 - $21.37 $3,878 - $7,308	-342 Reduced 2.32%	14,368 $173,000
Q2 2021 Aug 13, 2021	SELL	$19.4 - $28.71 $7,352 - $10,881	-379 Reduced 2.51%	14,710 $311,000
Q1 2021 May 07, 2021	BUY	$25.12 - $36.89 $1,004 - $1,475	40 Added 0.27%	15,089 $423,000
Q4 2020 Feb 12, 2021	SELL	$24.2 - $35.76 $10,430 - $15,412	-431 Reduced 2.78%	15,049 $391,000
Q3 2020 Nov 04, 2020	SELL	$31.18 - $52.71 $11,006 - $18,606	-353 Reduced 2.23%	15,480 $575,000
Q2 2020 Aug 12, 2020	BUY	$30.04 - $51.31 $25,503 - $43,562	849 Added 5.67%	15,833 $812,000
Q1 2020 May 04, 2020	SELL	$27.44 - $73.84 $23,790 - $64,019	-867 Reduced 5.47%	14,984 $472,000
Q4 2019 Feb 05, 2020	BUY	$35.4 - $59.82 $3,752 - $6,340	106 Added 0.67%	15,851 $945,000
Q3 2019 Nov 08, 2019	SELL	$34.47 - $47.53 $3,757 - $5,180	-109 Reduced 0.69%	15,745 $577,000
Q2 2019 Aug 13, 2019	BUY	$40.1 - $52.33 $50,646 - $66,092	1,263 Added 8.66%	15,854 $738,000
Q1 2019 May 06, 2019	SELL	$40.11 - $53.57 $18,972 - $25,338	-473 Reduced 3.14%	14,591 $586,000
Q4 2018 Feb 13, 2019	SELL	$36.99 - $59.11 $4,290 - $6,856	-116 Reduced 0.76%	15,064 $693,000
Q3 2018 Nov 09, 2018	BUY	$40.74 - $51.41 $11,122 - $14,034	273 Added 1.83%	15,180 $674,000
Q2 2018 Aug 08, 2018	BUY	$36.2 - $76.4 $139,225 - $293,834	3,846 Added 34.77%	14,907 $584,000
Q1 2018 May 07, 2018	SELL	$65.94 - $80.76 $24,331 - $29,800	-369 Reduced 3.23%	11,061 $800,000
Q4 2017 Feb 09, 2018	BUY	$43.47 - $67.43 $7,520 - $11,665	173 Added 1.54%	11,430 $753,000
Q3 2017 Nov 09, 2017	BUY	$43.8 - $52.77 $493,056 - $594,031	11,257	11,257 $564,000

Others Institutions Holding ESPR

# of Institutions

206

Shares Held

128M

Call Options Held

1.67M

Put Options Held

930K

View Full List

About Esperion Therapeutics, Inc.

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $156M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

More about ESPR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.

Account